shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
JAG-UCB-571deb56-3,Z5012901954,C24H21ClN4O2,Racemic or presumed racemic or meso,432.902,97.7,COVID-19,,,0,4,100,1181202-Y4-55,05_A,CC1=NC=CN1CC=2C=CC=3C(NC(=O)C4CCOC=5C=CC(Cl)=CC45)=CN=CC3C2,"6-chloro-N-{7-[(2-methyl-1H-imidazol-1-yl)methyl]isoquinolin-4-yl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3223345,41.6
ERI-UCB-8d4e5055-3,Z5012902006,C20H17ClN2O4S,Racemic or presumed racemic or meso,416.877,100,COVID-19,,,0,4,100,1181202-Y4-55,05_B,CS(=O)(=O)C=1C=CC=2C(NC(=O)C3CCOC=4C=CC(Cl)=CC34)=CN=CC2C1,"6-chloro-N-(7-methanesulfonylisoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3218398,25.2
MAT-POS-afb6844f-4,Z5018905125,C18H18ClN3O2,Racemic or presumed racemic or meso,343.807,100,COVID-19,,,0,4,100,1181202-Y4-55,05_C,NC=1C=NC=C(NC(=O)C2CCOC=3C=CC(Cl)=CC23)C1C4CC4,"N-(5-amino-4-cyclopropylpyridin-3-yl)-6-chloro-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3231684,29.4
EDJ-MED-ce467fd5-1,Z5060771469,C23H21ClN4O5S,Racemic or presumed racemic or meso,500.954,100,COVID-19,,,0,4,100,1181202-Y4-55,05_D,CNC(=O)CN1CC(C(=O)NC=2C=NC=C3C=CC(=CC23)S(=O)(=O)C)C=4C=C(Cl)C=CC4C1=O,"6-chloro-N-(6-methanesulfonylisoquinolin-4-yl)-2-[(methylcarbamoyl)methyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3231666,21.3
ERI-UCB-8d4e5055-6,Z5111388800,C27H26ClF3N4O4,Racemic or presumed racemic or meso,562.967,100,COVID-19,trifluoroacetic acid,1,114.0233496,4,100,1181202-Y4-55,05_E,OC(=O)C(F)(F)F.ClC=1C=CC=2OCCC(C(=O)NC=3C=NC=C4C=C(CN5CC6(CNC6)C5)C=CC34)C2C1,"6-chloro-N-[7-({2,6-diazaspiro[3.3]heptan-2-yl}methyl)isoquinolin-4-yl]-3,4-dihydro-2H-1-benzopyran-4-carboxamide; trifluoroacetic acid",H3231664,43.5
ALP-POS-5de921e7-1A,Z5021905551,C16H16ClN3O2,Racemic or presumed racemic or meso,317.770,100,COVID-19,,,0,4,100,1181202-Y4-55,05_F,CC=1C(N)=CN=CC1NC(=O)C2CCOC=3C=CC(Cl)=CC23,"N-(5-amino-4-methylpyridin-3-yl)-6-chloro-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3234918,20.5
ERI-UCB-8d4e5055-1,Z5015004628,C24H25ClN4O2,Racemic or presumed racemic or meso,436.933,97.17,COVID-19,,,0,4,100,1181202-Y4-55,05_G,ClC=1C=CC=2OCCC(C(=O)NC=3C=NC=C4C=C(CN5CCNCC5)C=CC34)C2C1,"6-chloro-N-{7-[(piperazin-1-yl)methyl]isoquinolin-4-yl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3218372,13.1
MAT-POS-14f31916-5,Z5012902028,C17H12Cl2N2O2S,Racemic or presumed racemic or meso,379.260,97.41,COVID-19,,,0,4,100,1181202-Y4-55,05_H,ClC1=CC=2C(NC(=O)C3CCOC=4C=CC(Cl)=CC34)=CN=CC2S1,"6-chloro-N-{2-chlorothieno[2,3-c]pyridin-4-yl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3229808,10.5
